Бизнес · 04.12.20121 мин чтения
Guidance on Investigational New Drug Applications for Positron Emission Tomography Drugs; Availability
Локальный автоматический перевод · Язык оригинального источника
Краткое содержание
The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled "Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs." The guidance is intended to assist manufacturers of PET drugs in submitting investigational new drug applications (INDs).